Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 975 of 984 entries
View as:

B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03327571 Org: User:
Start: 11/21/17 End: 10/31/19 Due: 10/31/20

A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada

Phase: N/A Priority: Normal
NCT ID: NCT05371028 Org: User:
Start: 09/23/23 End: 02/19/25 Due: 02/19/26

Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT

Phase: N/A Priority: Normal
NCT ID: NCT02728895 Org: User:
Start: 06/15/16 End: 07/10/18 Due: 07/10/19

Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.

Phase: N/A Priority: Normal
NCT ID: NCT00770640 Org: User:
Start: 08/31/08 End: 06/30/10 Due: 06/30/11

Adherence to PTH(1-84) Treatment (FP-002-IM)

Phase: N/A Priority: Normal
NCT ID: NCT00478569 Org: User:
Start: 04/30/07 End: 03/31/13 Due: 03/31/14

A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03370289 Org: User:
Start: 01/12/18 End: 02/28/18 Due: 02/28/19

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT00143663 Org: User:
Start: 09/30/05 End: 04/30/06 Due: 04/30/07

A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04157517 Org: User:
Start: 12/12/19 End: 12/20/23 Due: 12/20/24

A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT04943796 Org: User:
Start: 11/06/23 End: 11/30/25 Due: 11/30/26

A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT04776018 Org: User:
Start: 04/20/21 End: 11/09/23 Due: 11/09/24

Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01011751 Org: User:
Start: 04/30/04 End: 12/31/07 Due: 12/31/08

Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02170220 Org: User:
Start: 07/31/14 End: 12/31/14 Due: 12/31/15

Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01890122 Org: User:
Start: 09/30/13 End: 10/31/15 Due: 10/31/16

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02394834 Org: User:
Start: 05/29/15 End: 03/31/26 Due: 03/31/27

Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00395512 Org: User:
Start: 11/30/06 End: 02/29/08 Due: 02/28/09

Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00996281 Org: User:
Start: 10/31/09 End: 11/30/11 Due: 11/30/12

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04879849 Org: User:
Start: 09/09/21 End: 04/30/24 Due: 04/30/25

Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT03237156 Org: User:
Start: 08/07/17 End: 10/07/17 Due: 10/07/18

A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT02615184 Org: User:
Start: 05/23/23 End: 10/31/27 Due: 10/31/28

Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

Phase: N/A Priority: Normal
NCT ID: NCT00050076 Org: User:
Start: 08/31/02 End: 08/31/03 Due: 08/31/04

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT02151773 Org: User:
Start: 02/28/06 End: 04/30/09 Due: 04/30/10

A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02906813 Org: User:
Start: 09/12/16 End: 11/09/16 Due: 11/09/17

Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00735709 Org: User:
Start: 08/31/08 End: 08/31/09 Due: 08/31/10

Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00847626 Org: User:
Start: 01/31/09 End: 07/31/10 Due: 07/31/11

Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02614586 Org: User:
Start: 12/31/15 End: 04/30/16 Due: 04/30/17